文献速递乳腺MR

基于MRI影像组学预测乳腺癌新辅助全身治疗反应的系统综述

Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.
PubMed 文献 · Eur J Radiol · 2019-11-06

该系统综述纳入16项研究,评估基于MRI的影像组学预测乳腺癌新辅助全身治疗反应的方法学质量与结果。影像组学流程各步骤方法学异质性大,RQS评分0%至41.2%,熵是最佳单特征(AUC 0.83–0.85),最佳多变量模型验证AUC 0.94。作者认为结果总体有前景但难以比较,需标准化共识。

要点

  • 影像组学流程各步骤方法学差异大,结果异质性高、难以横向比较。
  • 熵为表现最佳的单特征,AUC 0.83–0.85;最佳多变量逻辑回归模型验证AUC 0.94。
  • 多数研究基于治疗前动态增强T1加权序列进行分析。

核心结论

  • 该系统综述揭示基于MRI的影像组学流程各步骤存在大量方法学异质性,导致总体有前景的结果难以比较。
  • 作者认为需要就乳腺癌新辅助全身治疗反应预测的MRI影像组学流程标准化达成共识,以进一步改进研究。

研究设计与样本

  • 系统综述,系统检索PubMed和EMBASE数据库,由两名评价者独立筛选摘要。
  • 纳入16项研究,队列样本量35至414例患者。
  • 采用影像组学质量评分(RQS)评估纳入研究的影像组学流程质量。

诊断标准与关键数值

  • RQS评分范围为0%至41.2%。
  • 7项研究采用单变量分析,9项研究采用多变量分析。
  • 熵为表现最佳的单特征,AUC值范围为0.83至0.85。
  • 基于逻辑回归分析的最佳多变量预测模型验证AUC为0.94。

临床应用与阅片要点

  • 多数研究基于治疗前动态增强T1加权序列进行影像组学分析。
  • 影像组学流程中感兴趣区分割、特征选择和模型开发的方法学差异大,可导致结果异质性。

局限性

  • 影像组学流程各步骤存在大量方法学异质性,导致结果难以比较。
  • RQS评分范围0%至41.2%,提示部分研究方法学质量有限。
  • 作者认为需要标准化共识以进一步改进研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: MRI-based tumor response prediction to neoadjuvant systemic therapy (NST) in breast cancer patients is increasingly being studied using radiomics with outcomes that appear to be promising. The aim of this study is to systematically review the current literature and reflect on its quality.

METHODS: PubMed and EMBASE databases were systematically searched for studies investigating MRI-based radiomics for tumor response prediction. Abstracts were screened by two reviewers independently. The quality of the radiomics workflow of eligible studies was assessed using the Radiomics Quality Score (RQS). An overview of the methodologies used in steps of the radiomics workflow and current results are presented.

RESULTS: Sixteen studies were included with cohort sizes ranging from 35 to 414 patients. The RQS scores varied from 0 % to 41.2 %. Methodologies in the radiomics workflow varied greatly, especially region of interest segmentation, features selection, and model development with heterogeneous outcomes as a result. Seven studies applied univariate analysis and nine studies applied multivariate analysis. Most studies performed their analysis on the pretreatment dynamic contrast-enhanced T1-weighted sequence. Entropy was the best performing individual feature with AUC values ranging from 0.83 to 0.85. The best performing multivariate prediction model, based on logistic regression analysis, scored a validation AUC of 0.94.

CONCLUSION: This systematic review revealed large methodological heterogeneity for each step of the MRI-based radiomics workflow, consequently, the (overall promising) results are difficult to compare. Consensus for standardization of MRI-based radiomics workflow for tumor response prediction to NST in breast cancer patients is needed to further improve research.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Granzier RWY, van Nijnatten TJA, Woodruff HC, et al. Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review. Eur J Radiol. 2019. PMID: 31734639. doi:10.1016/j.ejrad.2019.108736

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。